Share Name Share Symbol Market Type Share ISIN Share Description
Neuropharm LSE:NPH London Ordinary Share GB00B1NPJJ01 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 11.50p 0 06:30:09
Bid Price Offer Price High Price Low Price Open Price
0.00p 0.00p - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -4.9 -13.3 - 3.63

Neuropharm (NPH) Latest News

Real-Time news about Neuropharm (London Stock Exchange): 0 recent articles
More Neuropharm News
Neuropharm Takeover Rumours

Neuropharm (NPH) Share Charts

1 Year Neuropharm Chart

1 Year Neuropharm Chart

1 Month Neuropharm Chart

1 Month Neuropharm Chart

Intraday Neuropharm Chart

Intraday Neuropharm Chart

Neuropharm (NPH) Discussions and Chat

Neuropharm Forums and Chat

Date Time Title Posts
22/7/201110:42Neuropharm - Significant Undervaluation3,446
29/3/200911:01Neuropharm Group247

Add a New Thread

Neuropharm (NPH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Neuropharm trades in real-time

Neuropharm (NPH) Top Chat Posts

liarspoker: Fans of anomolities between the current share price and the delisting share price should look at JHL & DMG. Both share prices are trading lower than the take out price. You can place a lower offer in the case of JHL ( mine got filled at just over 76p ). The resolutions have passed for JHL but the EGM still has to be held for DMG. Profit margin is likely to be fairly small ( less than 10% for JHL and up to 20% for DGM ( as it carries the most risk at this stage until the resolution has been voted through ) so volume is needed.
boobly: ......interesting point . And , interesting that despite the depressing share price , the depressing way this has all been managed , and the depressing association with PIPJ , it seems that `Most` shareholders have been holding on . (Can`t be entirely due to the belief that stock is totally illiquid .)
boobly: Afternoon Guys !........Some thoughts : * This is still very dificult to fathom . * Only very limited news here . * I imagine The BoD were getting some real pressure from shareholders , and they have almost been forced to say `something` . * `Several intererested` , now seemm to be one , and still doing DD . So that suggests that there should be some value in their science and reasearch . Perhaps even the commercial viability of one / or more of their drugs . * I am very VERY , relieved indeed to see that the `Cash` is in effect intact . * I now believe that `Someone` DID (does?) want to buy the Company . * I wonder if leaks re` an approach were first apparent around August last year . * Looking at the share price movement since then , there were two spikes , and then a sudden collapse one month before the `Bid Talks` 3rd Nov . Since that time little obvious progress with talks , and a total collapse in the share price to around half cash value of the Company . (You could surely be forgiven for imagining this has been a deliberate act of sabotage.) * Obviously the benefit of these machinations would be appreciated by anyone wishing to buy the Company . * This has the `Hallmark` of something `Not quite Gentlemanly` about it . * Priced at half cash , are the years of research worth absolutely ZERO ? * Has the `Predator` been directly responsible for the current share price scenario ? * It wouldn`t be dificult , with so few shares in circulation . * How , could the major shareholders in the business possibly accept this situation ? * It looks like the business in it`s current format will be wound up , but these suggestions would surely only strengthen the position of any bidder . * I can`t help feeling that the BoD have handled this whole situation very badly . They need to bring this whole saga to a conclusion as quickly as possible . * Either the market thinks it`s all pants , or someone is dumping enough to keep this from rising . Also :...I mentioned a few days ago that I thought there had been a little bit of `Sneaky` buying , I think in amongst the odd bit of profit taking , and err ,,,,`Dumping` , there has again been some interesting buying (at the right price.).
warwick69: There is almost no risk whatsoever at buying at this price after today's announcement, as close to an odds on winner as you will ever get offerred, i am amazed at the share price reaction. (I am not just saying that because i hold, i am genuinely baffled)
duplicate book: borchardt..........thanks. So a nice premium then on the current share price. Might see a bit of sustained blue for NPH today, and that would make a refreshing change :o))
boobly: Yet again today I regard the trades , and the prices at which they were executed , as `Strange` in the context of their effect on the price of the stock , and , in the context of PIP`s short position . If I didn`t know better , (and I don`t!) I would believe that this stock has been (dishonestly ? fraudulently ?) manipulated to facilitate a cheap takeover , at a price that grossly undervalues the true worth of the Company`s cash and assets . The steady decline of the share price , during a `Sale period` looks highly suspicious . In these circumstances I would expect the Board of Directors to provide much more clarity about their efforts to realise value for ALL shareholders . If I were one of the Major %age shareholders in this Company , I would be creating a LOT of noise about the current valuation .... WHY are they not doing that ? We will eventually see an outcome that will either dispel totally these concerns , OR , a situation that will require serious investigation .
boobly: 08 December 2009 " Neuropharm Group Plc Continuing Discussions Neuropharm Group plc (AIM: NPH), a speciality pharmaceutical company focused on neurodevelopmental disorders, today provides an update to shareholders on developments in relation to the proposed sale or merger of the Company, as announced on 3 November 2009. Since the announcement, the Company has progressed discussions with an expanded number of third parties. Although discussions are at an early stage, the Board of Neuropharm continues to believe that shareholder value is more likely to be maximised through seeking a sale or merger partner which will be better placed to fund the Company's clinical development portfolio. A further update will be provided to shareholders in due course. " It seems to me that the market is view : `You`ve been saying this since March...Hurry up `. The view of some shareholders is : `You`ve been saying this since March...I can`t be bothered waiting any longer`. My view : `We have no option but to wait`. There has been very little volume selling , but , NO support from their advisers , ergo NO buying . (I suspect , that`s what they wanted , a soaring share price would be counter productive to achieving an appropriate sale price .) ....Having said that ....very disappointed :>( Anyone got an up to date view on their cash balance ?
borchardt: The fact that there are only 2 market makers working this stock is causing a negative impact on share price. Any sells increase pressure on market makers to move price down because they down want to take on too much stock.- Market makers do not like taking too much risk. New buyers are limited because stock is a bid situation and a drifting share price on a bid situation stock never looks appealing. Current price given prospects and cash position is far too low and although I expect company to be taken out at a decent premium to current price I think bidder(s) will take advantage of current price weakness and not pay what we are actually worth.
boobly: Agreed . What on earth have they been doing since march ? Who were these people ? What did they see of value ? Why did they disappear ? Who are NPH talking to ? What is their true strategy ? " RNS Number : 5427P Neuropharm Group PLC 26 March 2009 Neuropharm Group Plc ("Neuropharm" or "the Company") Share Price Movement Neuropharm Group plc (AIM: NPH), a specialty pharmaceutical company focused on developmental disorders, notes the existence of market rumour and the recent movement in its share price. The Company confirms that it received an indicative indication of interest with respect to a possible M&A transaction from a third party and that this interest is not being pursued. It further confirms that it is not currently in M&A discussions and is not aware of any specific reason for the share price movement. As detailed in the Company's half-year report for the six months ended 31 December 2008, announced on 17 March 2009, the Company had cash, cash equivalents and money market investments of GBP10.2 million at 31 December 2008. As noted in the joint statement from the Chairman and Chief Executive Officer, the Company is undertaking a detailed analysis and review of the future strategic alternatives for its lead programme NPL-2008 and for the Company, including the possibility of partnering NPL-2008 with a much larger pharmaceutical company. " .....You could go on and on asking questions , and I guess that is why the market is also questioning value here . My concern is that management have been ineffective as `Managers` , and yet they desperately want to hold onto their lucrative jobs . Anyone got an updated breakdown of the share register ?
quinan: Morning all, cheers lucky for that e-mail, how do we read that I might be inclined to say NPH had a much better offer for the licence deal of NPL2008 hence the termination of the first collaboration. NPH are still in negotiations but the north American company wants a bigger stake?? But this line from 28th of may indicates there was a lot of interest, NPH may have been able to choice the right one? "following considerable interest in NPL-2008 from a number of parties" Also for the statement on the 26th of March they state "The Company confirms that it received an indicative indication of interest with respect to a possible M&A transaction from a third party and that this interest is not being pursued. It further confirms that it is not currently in M&A discussions and is not aware of any specific reason for the share price movement. So was this what we already new regarding the termination of this deal? They clearly stated back in March they had already received indication of interest from a third party, but it would appear this company wanted to much of the pie with a M&A, clearly NPH have much more to offer and don't want to sell out cheaply??
Neuropharm share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20180320 00:05:06